With women managing nearly $32tn in global spending and, according to Nielsen, being set to control 75% of discretionary ...
How does the cost-effectiveness of treatments, particularly in relation to newer therapies, influence your recommendations for patients with BCG-unresponsive NMIBC? Are there specific tools or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback